World Trade Center Health Program Scientific/Technical Advisory Committee (WTCHP, STAC); Notice of Charter Renewal, 24152 [2019-10873]
Download as PDF
<![CDATA[
24152
Federal Register / Vol. 84, No. 101 / Friday, May 24, 2019 / Notices
Public Health Practice, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, Mailstop D–44,
Atlanta, Georgia 30329, Telephone:
(404) 639–7450; Fax: (404) 471–8772;
Email: OPHPR.BSC.Questions@cdc.gov.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2019–10871 Filed 5–23–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
World Trade Center Health Program
Scientific/Technical Advisory
Committee (WTCHP, STAC); Notice of
Charter Renewal
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of Charter Renewal.
AGENCY:
This gives notice that under
Public Law 111–347 (the James Zadroga
9/11 Health and Compensation Act of
2010), as amended by Public Law 114–
113, and the Federal Advisory
Committee Act (Pub. L. 92–463) of
October 6, 1972, the World Trade Center
Health Program Scientific/Technical
Advisory Committee, the Centers for
Disease Control and Prevention,
Department of Health and Human
Services, has been renewed for a 2-year
period through May 12, 2021.
FOR FURTHER INFORMATION CONTACT:
Tania Carreo´n-Valencia, Ph.D.,
Designated Federal Officer, WTCHP
STAC, National Institute for
Occupational Safety and Health, Centers
for Disease Control and Prevention,
Department of Health and Human
Services, 1600 Clifton Road NE, MS: R–
12, Atlanta, GA 30329; telephone (513)
841–4515; email TCarreonValencia@
cdc.gov.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
khammond on DSKBBV9HB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:10 May 23, 2019
Jkt 247001
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2019–10873 Filed 5–23–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
Agency Forms Undergoing Paperwork
Reduction Act Review
Proposed Project
National Syndromic Surveillance
Program (OMB Control No. 0920–0824,
Exp. 5/31/2019)—Revision—Center for
Surveillance, Epidemiology and
Laboratory Services (CSELS), Centers for
Disease Control and Prevention (CDC).
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled National
Syndromic Surveillance Program—
Revision to the Office of Management
and Budget (OMB) for review and
approval. CDC previously published a
‘‘Proposed Data Collection Submitted
for Public Comment and
Recommendations’’ notice on March 20,
2019 to obtain comments from the
public and affected agencies. CDC
received one comment related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
Background and Brief Description
Syndromic surveillance uses
syndromic data and statistical tools to
detect, monitor, and characterize
unusual activity for further public
health investigation or response.
Syndromic data include electronic
extracts of electronic health records
(EHRs) from patient encounter data from
emergency departments, urgent care,
ambulatory care, and inpatient
healthcare settings, as well as pharmacy
and laboratory data. Though these data
are being captured for different
purposes, they are monitored in near
real-time as potential indicators of an
event, a disease, or an outbreak of
public health significance. On the
national level, these data are used to
improve nationwide situational
awareness and enhance responsiveness
to hazardous events and disease
outbreaks to protect America’s health,
safety, and security.
The BioSense Program was created by
congressional mandate as part of the
Public Health Security and Bioterrorism
Preparedness and Response Act of 2002
and was launched by the CDC in 2003.
The BioSense Program has since been
expanded into the National Syndromic
Surveillance Program (NSSP) which
promotes and advances development of
a syndromic surveillance system for the
timely exchange of syndromic data.
CDC requests a three-year approval for
a Revision for NSSP (OMB Control No.
0920–0824, Expiration Date 5/31/2019).
This Revision includes a new request
for approval to receive onboarding data
from state, local and territorial public
health departments about healthcare
facilities in their jurisdiction.
NSSP features the BioSense Platform
and a collaborative Community of
Practice. The BioSense Platform is a
secure integrated electronic health
information system that CDC provides,
primarily for use by state, local and
Centers for Disease Control and
Prevention
[30Day–19–0824]
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
E:\FR\FM\24MYN1.SGM
24MYN1
]]>Agencies
[Federal Register Volume 84, Number 101 (Friday, May 24, 2019)]
[Notices]
[Page 24152]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-10873]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
World Trade Center Health Program Scientific/Technical Advisory
Committee (WTCHP, STAC); Notice of Charter Renewal
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of Charter Renewal.
-----------------------------------------------------------------------
SUMMARY: This gives notice that under Public Law 111-347 (the James
Zadroga 9/11 Health and Compensation Act of 2010), as amended by Public
Law 114-113, and the Federal Advisory Committee Act (Pub. L. 92-463) of
October 6, 1972, the World Trade Center Health Program Scientific/
Technical Advisory Committee, the Centers for Disease Control and
Prevention, Department of Health and Human Services, has been renewed
for a 2-year period through May 12, 2021.
FOR FURTHER INFORMATION CONTACT: Tania Carre[oacute]n-Valencia, Ph.D.,
Designated Federal Officer, WTCHP STAC, National Institute for
Occupational Safety and Health, Centers for Disease Control and
Prevention, Department of Health and Human Services, 1600 Clifton Road
NE, MS: R-12, Atlanta, GA 30329; telephone (513) 841-4515; email
[email protected].
The Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-10873 Filed 5-23-19; 8:45 am]
BILLING CODE 4163-18-P
